King Michael N. 4
4 · PDS Biotechnology Corp · Filed Dec 9, 2020
Insider Transaction Report
Form 4
King Michael N.
Interim Chief Financial Office
Transactions
- Award
Stock Option (Right to Buy)
2020-12-08+50,000→ 50,000 totalExercise: $2.43Exp: 2030-12-08→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option is fully vested and immediately exercisable as of the date of grant.